Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Class A Ordinary Shares, par value $0.0001 per share
Shares outstanding
424,966,351
Total 13F shares
320,707,173
Share change
+6,055,853
Total reported value
$8,183,523,072
Put/Call ratio
23%
Price per share
$25.51
Number of holders
414
Value change
+$144,649,409
Number of buys
214
Number of sells
185

Quarterly Holders Quick Answers

What is CUSIP G7709Q104?
CUSIP G7709Q104 identifies RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q4 2024

As of 31 Dec 2024, Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by 414 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 320,707,173 shares. The largest 10 holders included MORGAN STANLEY, VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., BAILLIE GIFFORD & CO, VIKING GLOBAL INVESTORS LP, Swedbank AB, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 414 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.